Open Orphan #ORPH announces completion of the merger with hVIVO and re-admission January 20, 2020 – Posted in: Open Orphan (ORPH)

Open Orphan plc (ORPH), a rapidly growing specialist pharmaceutical services company which has a focus on orphan drugs, is pleased to announce that admission to trading on AIM and Euronext Growth of its existing ordinary share capital and the new ordinary shares to be issued as consideration in connection with the Merger, will commence at 8.00 a.m. today. Highlights: · Completion of merger between Open Orphan and hVIVO creating a European full pharma services company in a compelling…

Open Orphan #ORPH – Interim Results for 6 months ended 30 June 2019 September 25, 2019 – Posted in: Open Orphan (ORPH)

Open Orphan, a European-focused, rare and orphan drug consulting services platform, announces its interim results for the six months ended 30 June 2019. Financial Highlights below (and in note 3 of the reported financial statements) reflect the interim results of Venn Life Sciences (“Venn”) prior to the reverse takeover by Open Orphan on the 28 June 2019. Reported results, based on IFRS accounting rules, reflect those of Open Orphan DAC while the Balance Sheet as of…

Open Orphan #ORPH announces completion of the merger with hVIVO and re-admission January 20, 2020 – Posted in: Open Orphan (ORPH)

Open Orphan #ORPH – Interim Results for 6 months ended 30 June 2019 September 25, 2019 – Posted in: Open Orphan (ORPH)

Address

Contact

Social

LEGAL